triazoles has been researched along with Pulmonary Aspergillosis in 97 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 11 (11.34) | 29.6817 |
2010's | 70 (72.16) | 24.3611 |
2020's | 16 (16.49) | 2.80 |
Authors | Studies |
---|---|
Eller, P; Gorkiewicz, G; Hatzl, S; Hoenigl, M; Krause, R; Metnitz, P; Pilz, S; Posch, F; Prattes, J; Prüller, F; Reisinger, AC; Rief, M; Rosenkranz, AR; Schilcher, G; Schoerghuber, M; Stradner, M; Toller, W; Valentin, T | 1 |
Buil, JB; den Dekker, BM; Festen, B; Heusinkveld, M; Melchers, M; Mooren, ERM; Schellaars, R; van Binsbergen, AL; van Bree, SHW; van Zanten, ARH; Verweij, PE | 1 |
Cai, L; Chen, C; Dai, C; Gao, P; Ilkit, M; Ning, Y; Wang, Z; Xiao, J; Xue, X | 1 |
Akashi, K; Izumikawa, K; Kakeya, H; Kamei, K; Kanda, Y; Kimura, SI; Kishida, M; Kohno, S; Matsuda, M; Miyazaki, T; Miyazaki, Y; Mukae, H; Niki, Y; Ogawa, K; Okada, F; Suzuki, J; Takazono, T; Taniguchi, S; Tateda, K; Yoshida, M | 1 |
Armstrong-James, D; Bromley, M; Kosmidis, C | 1 |
Bellomo, R; Costa-Pinto, R; Finlay, L; Klink, S; Perera, P; Rotherham, H; Trubiano, J; Urbancic, K; Vaz, K | 1 |
Bellanger, AP; Berceanu, A; Daguindau, E; Desbrosses, Y; Millon, L; Rocchi, S; Scherer, E | 1 |
Arikan-Akdagli, S; Dogan, R; Gülmez, D; Karcioglu, O; Selcuk, ZT; Tokat, F; Uzun, O | 1 |
Agarwal, R; Dhooria, S; Muthu, V; Prasad, KT; Sehgal, IS | 1 |
Böll, B; Böttiger, BW; Cornely, OA; Dusse, F; Eichenauer, DA; Fuchs, F; Hallek, M; Jung, N; Klein, F; Kochanek, M; Koehler, P; Persigehl, T; Rybniker, J; Shimabukuro-Vornhagen, A | 1 |
Arron, ST; Brownell, I; Cahoon, EK; Cowen, EW; D'Arcy, ME; Engels, EA; Hess, GP; Israni, AK; Pfeiffer, RM; Rivera, DR; Triplette, MA; Yanik, EL | 1 |
Bassetti, M; Böll, B; Brüggemann, R; Chakrabarti, A; Chen, SCA; Colombo, AL; Cornely, OA; Gangneux, JP; Hoenigl, M; Klimko, N; Koehler, P; Lass-Flörl, C; Meis, JF; Oladele, RO; Ostrosky-Zeichner, L; Patterson, TF; Perfect, JR; Persigehl, T; Verweij, PE; Vinh, DC; White, PL; Zhu, LP | 1 |
Chen, W; Li, R; Liang, T; Liu, W; Osherov, N; Wan, Z; Wang, Q; Yang, E; Yang, X | 1 |
Ben-Ami, R; Handelman, M; Liu, W; Morogovsky, A; Osherov, N | 1 |
Barcelo-Vidal, J; Carballo, N; Conde-Estévez, D; De-Antonio Cuscó, M; Echeverria-Esnal, D; Ferrández, O; Grau, S; Horcajada, JP; Martín-Ontiyuelo, C; Navarrete-Rouco, ME | 1 |
Beishuizen, A; Cornet, AD; Masselink, JB; Mian, P; Sportel, ET; Trof, RJ | 1 |
Chang, D; McHardy, I; Semrad, A; Thompson, GR; Wittenberg, RR | 1 |
Harris, C; Morales, MK; Shoham, S | 1 |
Bedin Denardi, L; de Azevedo, MI; Hartz Alves, S; Keller, JT; Morais Santurio, J; Oliveira, V; Pantella Kunz de Jesus, F; Weiblen, C | 1 |
Chen, J; Qian, L; Shen, J; Yang, X; Zhang, Y | 1 |
Denning, DW; Harris, C; Kosmidis, C; Muldoon, EG; Newton, PJ; Rodriguez-Goncer, I | 1 |
Della Pepa, R; Giordano, C; Grimaldi, F; Mortaruolo, C; Pane, F; Picardi, M; Pugliese, N; Raimondo, M; Salvatore, P; Sirignano, C; Trastulli, F; Zacheo, I | 1 |
Abdallah, N; Kanj, A; Soubani, AO | 1 |
Bongomin, F; Felton, T; Maguire, N; Moore, CB; Rautemaa-Richardson, R | 1 |
Denning, DW; Kosmidis, C; Moore, CB; Rautemaa-Richardson, R; Richardson, MD; Rodriguez-Goncer, I | 1 |
Castagnola, E; De Leonardis, F; Giannico, B; Mariggiò, MA; Novielli, C; Santoro, N | 1 |
Colley, T; Daly, L; Ito, K; Kimura, G; Kizawa, Y; Nakaoki, T; Nishimoto, Y; Rapeport, G; Sehra, G; Strong, P | 1 |
Alanio, A; Bretagne, S; Chowdhary, A; Colley, T; Daly, L; Ito, K; Kimura, G; Kizawa, Y; Meis, JF; Nakaoki, T; Nishimoto, Y; Rapeport, G; Sharma, C; Strong, P | 1 |
Chu, HY; Fredricks, DN; Jain, R; Pottinger, P; Xie, H | 1 |
Campoli, C; Capone, A; Chiappetta, D; Chinello, P; Di Bella, S; Petrosillo, N | 1 |
El-Sherief, A; Gordon, S; Olbrych, T; Tedja, R | 1 |
Fox, DA; Gladue, HS | 1 |
Chen, F; Shi, Y; Su, X; Sun, WK; Xu, XY; Zhang, M | 1 |
Bucknor, MD; Gross, AJ; Link, TM | 1 |
Ando, T; Kawashima, M; Koyama, K; Matsui, H; Nagai, H; Ohshima, N; Ohta, K; Sato, R; Suzuki, J; Takeda, K | 1 |
Chan, T; Ding, WY; McWilliams, R; Yadavilli, RK | 1 |
Ahmad, S; Joseph, L; Khan, Z | 1 |
Berg, T; Brandmaier, P; Jonas, S; Lübbert, C; Mohr, FW; Pfeiffer, D; Rodloff, A; Schmelzle, M; Schubert, S; Wiltberger, G | 1 |
Kikuchi, T; Kikuchi, Y; Miki, H; Nishimaki, K; Saito, W; Sasamori, K; Shishikura, Y | 1 |
Cadranel, J; Cateau, E; Frat, JP; Godet, C; Goudet, V; Gounant, V; Laurent, F; Le Moal, G; Roblot, F | 1 |
Cheng, MP; Parkes, LO; Sheppard, DC | 1 |
Buitrago, MJ; Cendejas-Bueno, E; Forastiero, A; Gavaldà, J; Gomez-Lopez, A; Mellado, E; Ruiz, I | 1 |
Barao Ocampo, M; Biffi, A; Colombo, C; De Lorenzis, G; Esposto, MC; Favuzzi, V; Koncan, R; Lo Cascio, G; Pizzamiglio, G; Prigitano, A; Romanò, L; Tortorano, AM | 1 |
Al-Shair, K; Denning, DW; Harris, C; Lowes, D; Morris, J; Newton, PJ; Rautemaa-Richardson, R | 1 |
Iseman, MD; Peloquin, CA; Schwiesow, JN | 1 |
Kanazawa, K; Niki, Y; Takemoto, K; Ueda, Y; Yamamoto, Y; Yoshida, K | 1 |
Baba, T; Endo, T; Enomoto, T; Hagiwara, E; Kato, T; Komatsu, S; Matsushima, A; Nishihira, R; Ogura, T; Sekine, A; Shiihara, J; Shinohara, T; Sogo, Y; Tagawa, A; Takahashi, H; Tsuchiya, N | 1 |
Maertens, J; Meersseman, W; Van Bleyenbergh, P | 1 |
Ayats, J; Fernández, N; Gasch, O; Santin, M | 1 |
Avila, NA; Bacher, J; Cotton, MP; Francesconi, A; Hope, WW; Hughes, JE; Kasai, M; Meletiadis, J; Mickiene, D; Petraitiene, R; Petraitis, V; Schaufele, RL; Sein, T; Stergiopoulou, T; Walsh, TJ | 1 |
Han, FC; Jureen, R; Tew, CW; Tey, BH | 1 |
Choe, DH; Kang, MS; Kim, CH; Lee, JC; Noh, GY | 1 |
Alffenaar, JW; Daenen, SM; Kosterink, JG; Uges, DR; van der Elst, KC | 1 |
Altman, R; Belperio, JA; Eshaghian, P; Gregson, A; Kubak, B; Lynch, JP; Ross, DJ; Saggar, R; Wang, T; Wang, TF; Weigt, SS | 1 |
Bellete, B; Flori, P; Hafid, J; Manhsung, RT; Morel, J; Raberin, H | 1 |
Duval, A; Hickman, G; Petit, A; Picard, C | 1 |
Wingard, J | 1 |
Furuya, A; Ida, K; Kato, M; Koh, K; Okamoto, T; Takita, J | 1 |
Chudgar, SM; Norton, BL; Person, AK; Stout, JE; Tong, BC | 1 |
Segal, BH; Sherif, R | 1 |
Higashimoto, I; Koreeda, Y; Mataki, H; Matsuda, T; Noma, S; Taira, T | 1 |
Cheng, MP; Lands, LC; Ovetchkine, P; Paquette, K; Quach, C; Théoret, Y | 1 |
Berrak, SG; Cakir, E; Cakir, FB; Canpolat, C; Dagli, E; Karakoc, F; Uyan, ZS | 1 |
Meersseman, W | 1 |
Ahmad, S; Burhamah, MHA; Khan, ZU; Mokaddas, E | 1 |
Amitani, R; Izumikawa, K; Kakeya, H; Kohno, S; Kurashima, A; Miyazaki, Y; Niki, Y; Ogawa, K; Okimoto, N | 1 |
Huang, Y; Li, HY; Liu, L; Wang, GY; Xia, ZF; Zhang, JR; Zhu, SH | 1 |
Izumikawa, K; Kohno, S | 1 |
Baxter, C; Denning, DW; Felton, TW; Hope, WW; Moore, CB; Roberts, SA | 1 |
Bierings, MB; Melchers, WJ; Thors, VS; Verweij, PE; Wolfs, TF | 1 |
Ayub, A; Kenney, CV; McKiernan, FE | 1 |
Bedouch, P; Belaiche, S; Pison, C; Quetant, S; Roustit, M; Saint-Raymond, C | 1 |
Kuithan, F; Scheer, F; Wiggermann, P | 1 |
Pena, TA; Samavati, L; Soubani, AO | 1 |
Hoshika, Y; Kato, M; Katsura, Y; Kikuchi, K; Misawa, S; Nagaoka, T; Ohashi, R; Seyama, K; Sugawara, T; Takahashi, K; Takekawa, H; Togo, S; Tsuchiya, K; Yoshimi, K | 1 |
Bowyer, P; Bueid, A; Denning, DW; Fraczek, MG; Gore, R; Kirwan, M; Lass-Florl, C; Moore, CB; Park, S; Perlin, DS; Smith, J | 1 |
Brizio, A; Cantoni, S; Lombardi, G; Morra, E; Nosari, A; Riva, M | 1 |
Malfertheiner, MV; Schreiber, J; Waldburg, N | 1 |
Bignell, EM; Cairns, T; Doyle, S; Kavanagh, K; Larsen, TO; Miggin, SM; O'Hanlon, KA; O'Keeffe, G; Schrettl, M; Stack, D | 1 |
Björkholm, M; Celsing, F; Grane, P; Kalin, M | 1 |
Atalay, S; Aypar, E; Çiftçi, E; Ileri, T; Ince, E; Kendirli, T; Tutar, E | 1 |
Chowdhary, A; Gaur, SN; Kathuria, S; Klaassen, CH; Meis, JF; Randhawa, HS | 1 |
Bahlaoui, A; Bakhatar, A; Chakib, A; El Fane, M; El Filali, KM; Ouladlahsen, A; Sodqi, M | 1 |
Alcazar-Fuoli, L; Bignell, E; Blatzer, M; Cairns, T; Grimalt, JO; Gründlinger, M; Haas, H; Lopez, JF; Puempel, T; Yasmin, S | 1 |
Patterson, TF; Thompson, GR | 1 |
Kikuti, K | 1 |
Hirano, K; Hosogaya, N; Ide, S; Imamura, Y; Izumikawa, K; Kakeya, H; Kohno, S; Kurihara, S; Mihara, T; Miyazaki, T; Morinaga, Y; Nakamura, S; Nishino, T; Takazono, T; Tashiro, M; Tashiro, T; Tsukamoto, M; Yamamoto, Y; Yanagihara, K; Yasuoka, A | 1 |
Andersen, CU; Bendstrup, E; Henning, O; Hilberg, O; Lundby, T; Mortensen, J | 1 |
Bergeron, A; Bergot, E; Bourdin, A; Cadranel, J; Cottin, V; Germaud, P; Godet, C; Hennequin, C; Jeanfaivre, T; Philippe, B; Pineau, M | 1 |
Debaveye, Y; Grootaert, V; Meyfroidt, G; Spriet, I; Willems, L | 1 |
Chandrasekar, PH; Cutright, JL; Krishnan Natesan, S; Wu, W | 1 |
Fujiuchi, S; Kato, T; Kawabata, M; Kuba, M; Kurashima, A; Ogawa, K; Saito, T; Sakatani, M; Sasaki, Y; Suzuki, K; Tada, A; Tao, Y | 1 |
Buendía, B; Cuenca-Estrella, M; De La Camara, R; Mellado, E; Rodriguez-Tudela, JL | 1 |
Campo, S; De Santis, R; Lo Giudice, P; Salvatori, G | 1 |
Albarrag, AM; Anderson, MJ; Bowyer, P; Denning, DW; Gregson, L; Harrison, E; Howard, SJ; Leatherbarrow, H; Pasqualotto, AC | 1 |
Del Rosario, RC; Halloush, RA; Khasawneh, FA | 1 |
Clauss, H; Samuel, R | 1 |
13 review(s) available for triazoles and Pulmonary Aspergillosis
Article | Year |
---|---|
Lung and gut microbiomes in pulmonary aspergillosis: Exploring adjunctive therapies to combat the disease.
Topics: Antifungal Agents; Aspergillus; Aspergillus fumigatus; Gastrointestinal Microbiome; Humans; Lung; Pulmonary Aspergillosis; Triazoles | 2022 |
Update on the treatment of chronic pulmonary aspergillosis.
Topics: Antifungal Agents; Cytokines; Echinocandins; Humans; Pulmonary Aspergillosis; Triazoles | 2023 |
An overview of the available treatments for chronic cavitary pulmonary aspergillosis.
Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Disease Management; Echinocandins; Humans; Itraconazole; Nitriles; Practice Guidelines as Topic; Pulmonary Aspergillosis; Pyridines; Triazoles; Voriconazole | 2020 |
Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance.
Topics: Amphotericin B; Antifungal Agents; Azoles; Coinfection; COVID-19; Humans; Nitriles; Pulmonary Aspergillosis; Pyridines; SARS-CoV-2; Triazoles; Voriconazole | 2021 |
Pharmacological management of antifungal agents in pulmonary aspergillosis: an updated review.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Humans; Pulmonary Aspergillosis; Triazoles | 2022 |
Graded isavuconazole introduction in a patient with voriconazole allergy.
Topics: Amphotericin B; Angioedema; Antifungal Agents; Aspergillus; Desensitization, Immunologic; Drug Administration Schedule; Drug Hypersensitivity; Female; Humans; Liver Cirrhosis; Liver Transplantation; Lung; Middle Aged; Nitriles; Pulmonary Aspergillosis; Pyridines; Tomography, X-Ray Computed; Treatment Outcome; Triazoles; Voriconazole | 2017 |
The spectrum of pulmonary aspergillosis.
Topics: Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Aspergillus; Environmental Exposure; Fungi; Humans; Invasive Pulmonary Aspergillosis; Nitriles; Prognosis; Pulmonary Aspergillosis; Pyridines; Recurrence; Triazoles | 2018 |
Multifocal periostitis as a complication of chronic use of voriconazole in a lung transplant recipient.
Topics: Aged; Antifungal Agents; Chemoprevention; Female; Humans; Lung Diseases, Fungal; Lung Transplantation; Male; Periostitis; Pulmonary Aspergillosis; Pyrimidines; Triazoles; Voriconazole | 2013 |
Nebulised liposomal amphotericin B for Aspergillus lung diseases: case series and literature review.
Topics: Aged; Amphotericin B; Antifungal Agents; Aspergillus; Contraindications; Female; Humans; Immunocompromised Host; Immunosuppressive Agents; Male; Middle Aged; Nebulizers and Vaporizers; Pulmonary Aspergillosis; Triazoles | 2015 |
New therapies for fungal pneumonia.
Topics: Amphotericin B; Antifungal Agents; Fungi; Galactose; Humans; Mannans; Mycoses; Pneumonia; Pulmonary Aspergillosis; Pyrimidines; Radiography, Thoracic; Triazoles; Voriconazole | 2009 |
Pulmonary aspergillosis: clinical presentation, diagnostic tests, management and complications.
Topics: Amphotericin B; Antifungal Agents; Antigens, Fungal; Aspergillus; DNA, Fungal; Female; Fungemia; Humans; Immunocompromised Host; Incidence; Male; Prognosis; Pulmonary Aspergillosis; Pyrimidines; Risk Assessment; Severity of Illness Index; Survival Rate; Triazoles; Voriconazole | 2010 |
Aspergillus lung disease in patients with sarcoidosis: a case series and review of the literature.
Topics: Adult; Aged; Antifungal Agents; Female; Humans; Itraconazole; Male; Middle Aged; Pulmonary Aspergillosis; Pyrimidines; Risk Factors; Sarcoidosis, Pulmonary; Treatment Outcome; Triazoles; Voriconazole | 2011 |
Pulmonary aspergillosis: recent advances.
Topics: Amphotericin B; Antifungal Agents; Aspergillus; Disease Susceptibility; Drug Resistance, Fungal; Echinocandins; Humans; Immunocompromised Host; Invasive Pulmonary Aspergillosis; Opportunistic Infections; Pulmonary Aspergillosis; Triazoles | 2011 |
3 trial(s) available for triazoles and Pulmonary Aspergillosis
Article | Year |
---|---|
Efficacy and safety of isavuconazole against deep-seated mycoses: A phase 3, randomized, open-label study in Japan.
Topics: Antifungal Agents; Aspergillosis; Cryptococcosis; Humans; Invasive Fungal Infections; Japan; Mucormycosis; Pulmonary Aspergillosis; Triazoles; Voriconazole | 2023 |
Intravenous micafungin versus voriconazole for chronic pulmonary aspergillosis: a multicenter trial in Japan.
Topics: Aged; Aged, 80 and over; Antifungal Agents; Aspergillus; Chronic Disease; Echinocandins; Female; Humans; Infusions, Intravenous; Japan; Lipopeptides; Male; Micafungin; Microbial Sensitivity Tests; Middle Aged; Pulmonary Aspergillosis; Pyrimidines; Radiography; Treatment Outcome; Triazoles; Voriconazole | 2010 |
Voriconazole for chronic pulmonary aspergillosis: a prospective multicenter trial.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Aspergillus fumigatus; Chronic Disease; Drug-Related Side Effects and Adverse Reactions; Endoscopy; Female; Humans; Male; Middle Aged; Prospective Studies; Pulmonary Aspergillosis; Pyrimidines; Radiography, Thoracic; Tomography, X-Ray Computed; Treatment Outcome; Triazoles; Voriconazole | 2012 |
81 other study(ies) available for triazoles and Pulmonary Aspergillosis
Article | Year |
---|---|
Antifungal prophylaxis for prevention of COVID-19-associated pulmonary aspergillosis in critically ill patients: an observational study.
Topics: Aged; Antifungal Agents; COVID-19; Critical Illness; Female; Humans; Intensive Care Units; Male; Middle Aged; Pulmonary Aspergillosis; Respiratory Distress Syndrome; Triazoles | 2021 |
A 67-Year-Old Male Patient With COVID-19 With Worsening Respiratory Function and Acute Kidney Failure.
Topics: Acute Kidney Injury; Aged; Amphotericin B; Antibodies, Monoclonal, Humanized; Antifungal Agents; Atrial Fibrillation; Bronchoscopy; COVID-19; Dexamethasone; Diabetes Mellitus, Type 2; Fatal Outcome; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Mucormycosis; Nitriles; Obesity; Oxygen Inhalation Therapy; Pulmonary Aspergillosis; Pyridines; Respiration, Artificial; SARS-CoV-2; Smoking; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2022 |
Assessing the safety profile of voriconazole use in suspected COVID-19-associated pulmonary aspergillosis-a two-centre observational study.
Topics: Animals; Antifungal Agents; COVID-19; Pulmonary Aspergillosis; Retrospective Studies; Triazoles; Voriconazole | 2023 |
Invasive Fungal Disease, Isavuconazole Treatment Failure, and Death in Acute Myeloid Leukemia Patients.
Topics: Antifungal Agents; Aspergillus fumigatus; Diagnosis, Differential; Fatal Outcome; Humans; Immunocompromised Host; Leukemia, Myeloid, Acute; Male; Middle Aged; Nitriles; Pulmonary Aspergillosis; Pyridines; Treatment Failure; Triazoles | 2019 |
A Rare Presentation of Pulmonary Aspergillosis: Bronchial Stump Aspergillosis.
Topics: Aftercare; Antifungal Agents; Aspergillus flavus; Biopsy; Bronchial Diseases; Bronchoscopy; Female; Humans; Lung Diseases, Fungal; Middle Aged; Postoperative Complications; Pulmonary Aspergillosis; Treatment Outcome; Triazoles | 2020 |
COVID-19 associated pulmonary aspergillosis.
Topics: Aged; Antifungal Agents; Bronchoalveolar Lavage Fluid; Coronavirus Infections; COVID-19; Female; Galactose; Germany; Hemorrhage; Hospitals, Teaching; Humans; Intensive Care Units; Lung Diseases; Male; Mannans; Metapneumovirus; Middle Aged; Nitriles; Pandemics; Paramyxoviridae Infections; Pneumonia, Viral; Pulmonary Aspergillosis; Pyridines; Respiratory Distress Syndrome; Retrospective Studies; Thorax; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2020 |
Voriconazole and the Risk of Keratinocyte Carcinomas Among Lung Transplant Recipients in the United States.
Topics: Aged; Antifungal Agents; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Female; Follow-Up Studies; Humans; Incidence; Itraconazole; Lung Transplantation; Male; Middle Aged; Pulmonary Aspergillosis; Skin Neoplasms; Triazoles; United States; Voriconazole | 2020 |
Emergence of W272C Substitution in Hmg1 in a Triazole-Resistant Isolate of Aspergillus fumigatus from a Chinese Patient with Chronic Cavitary Pulmonary Aspergillosis.
Topics: Antifungal Agents; Aspergillus fumigatus; China; Drug Resistance, Fungal; Fungal Proteins; HMGB1 Protein; Humans; Microbial Sensitivity Tests; Mutation; Pulmonary Aspergillosis; Triazoles | 2021 |
Triazole-Resistant Aspergillus fumigatus in an Israeli Patient with Chronic Cavitary Pulmonary Aspergillosis Due to a Novel E306K Substitution in Hmg1.
Topics: Antifungal Agents; Aspergillus fumigatus; Drug Resistance, Fungal; Fungal Proteins; HMGB1 Protein; Humans; Pulmonary Aspergillosis; Triazoles | 2021 |
Suboptimal plasma concentrations with posaconazole suspension as prophylaxis in critically ill COVID-19 patients at risk of Covid-associated pulmonary aspergillosis.
Topics: Antifungal Agents; COVID-19; Critical Illness; Humans; Pulmonary Aspergillosis; Triazoles | 2022 |
Topics: 11-beta-Hydroxysteroid Dehydrogenases; Aged; Antifungal Agents; Cortisone; Humans; Hydrocortisone; Hypertension; Hypokalemia; Lung; Male; Mineralocorticoid Excess Syndrome, Apparent; Pulmonary Aspergillosis; Triazoles | 2017 |
Evaluation of the efficacy of a posaconazole and anidulafungin combination in a murine model of pulmonary aspergillosis due to infection with Aspergillus fumigatus.
Topics: Anidulafungin; Animals; Antifungal Agents; Aspergillus fumigatus; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Echinocandins; Female; Lung; Mice; Pulmonary Aspergillosis; Treatment Outcome; Triazoles | 2018 |
Successful Treatment of Lung Aspergillus terreus Infection After a Second Hematopoietic Stem Cell Transplant in a Patient With Myelodysplastic Syndrome.
Topics: Antifungal Agents; Hematopoietic Stem Cell Transplantation; Humans; Male; Micafungin; Myelodysplastic Syndromes; Postoperative Complications; Pulmonary Aspergillosis; Remission Induction; Triazoles; Young Adult | 2019 |
Assessment of posaconazole salvage therapy in chronic pulmonary aspergillosis using predefined response criteria.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Aspergillus fumigatus; Chronic Disease; Female; Humans; Male; Middle Aged; Pulmonary Aspergillosis; Retrospective Studies; Salvage Therapy; Surveys and Questionnaires; Survival Analysis; Treatment Outcome; Triazoles | 2018 |
(1-3)-β-D-Glucan serum increase and small-airway-invasive radiological findings as early signs of pulmonary aspergillosis in high-risk hematologic patients in the posaconazole era: preliminary observations.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; beta-Glucans; Cytarabine; Daunorubicin; Female; Humans; Idarubicin; Leukemia, Myeloid, Acute; Male; Middle Aged; Pulmonary Aspergillosis; Retrospective Studies; Risk Factors; Triazoles; Vidarabine | 2019 |
Isavuconazole and voriconazole for the treatment of chronic pulmonary aspergillosis: A retrospective comparison of rates of adverse events.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Chronic Disease; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Male; Middle Aged; Nitriles; Pulmonary Aspergillosis; Pyridines; Retrospective Studies; Triazoles; United Kingdom; Voriconazole | 2019 |
Therapeutic drug monitoring and adverse events of delayed-release posaconazole tablets in patients with chronic pulmonary aspergillosis.
Topics: Administration, Oral; Adult; Aged; Antifungal Agents; Chronic Disease; Delayed-Action Preparations; Drug Monitoring; Female; Humans; Male; Middle Aged; Pulmonary Aspergillosis; Tablets; Treatment Outcome; Triazoles | 2019 |
Isavuconazole Treatment of Cerebral and Pulmonary Aspergillosis in a Pediatric Patient With Acute Lymphoblastic Leukemia: Case Report and Review of Literature.
Topics: Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillus; Child, Preschool; Female; Humans; Neuroaspergillosis; Nitriles; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Pulmonary Aspergillosis; Pyridines; Triazoles | 2020 |
Antifungal synergy of a topical triazole, PC945, with a systemic triazole against respiratory Aspergillus fumigatus infection.
Topics: Administration, Topical; Antifungal Agents; Aspergillus fumigatus; Benzamides; Cell Line; Drug Synergism; Humans; Pulmonary Alveoli; Pulmonary Aspergillosis; Triazoles; Voriconazole | 2019 |
Anti-fungal activity of a novel triazole, PC1244, against emerging azole-resistant Aspergillus fumigatus and other species of Aspergillus.
Topics: Animals; Antifungal Agents; Aspergillus; Colony Count, Microbial; Disease Models, Animal; France; Galactose; Humans; India; Lung; Mannans; Mice; Microbial Sensitivity Tests; Netherlands; Pulmonary Aspergillosis; Treatment Outcome; Triazoles | 2019 |
Voriconazole therapeutic drug monitoring: retrospective cohort study of the relationship to clinical outcomes and adverse events.
Topics: Adult; Antifungal Agents; Brain Diseases, Metabolic; Candidiasis; Drug Administration Schedule; Drug Monitoring; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Liver; Male; Middle Aged; Pulmonary Aspergillosis; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Voriconazole | 2013 |
Multiple bilateral pulmonary "fungus balls" in an immunocompetent patient unsuitable for surgical treatment: efficacy of azoles treatment.
Topics: Aged; Antifungal Agents; Humans; Lung; Male; Mycetoma; Pulmonary Aspergillosis; Pyrimidines; Radiography; Treatment Outcome; Triazoles; Voriconazole | 2013 |
Voriconazole-induced periostitis causing arthralgias mimicking a flare of granulomatosis with polyangiitis.
Topics: Aged; Alkaline Phosphatase; Antifungal Agents; Arthralgia; Diagnosis, Differential; Disease Progression; Female; Granulomatosis with Polyangiitis; Hip Joint; Humans; Periostitis; Pulmonary Aspergillosis; Pyrimidines; Triazoles; Voriconazole | 2013 |
Efficacy of the combination of voriconazole and caspofungin in experimental pulmonary aspergillosis by different Aspergillus species.
Topics: Animals; Antifungal Agents; Aspergillus flavus; Aspergillus fumigatus; Aspergillus niger; Caspofungin; Disease Models, Animal; Drug Therapy, Combination; Echinocandins; Galactose; Humans; Lipopeptides; Male; Mannans; Microbial Sensitivity Tests; Neutropenia; Pulmonary Aspergillosis; Pyrimidines; Rats; Rats, Sprague-Dawley; Treatment Outcome; Triazoles; Voriconazole | 2014 |
Voriconazole-induced periostitis in two post-transplant patients.
Topics: Antifungal Agents; Female; Heart Transplantation; Humans; Male; Middle Aged; Opportunistic Infections; Periostitis; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pulmonary Aspergillosis; Pyrimidines; Radionuclide Imaging; Radiopharmaceuticals; Stem Cell Transplantation; Technetium Tc 99m Medronate; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2013 |
Recurrence of chronic pulmonary aspergillosis after discontinuation of maintenance treatment by antifungal triazoles.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Female; Humans; Maintenance Chemotherapy; Male; Middle Aged; Pulmonary Aspergillosis; Recurrence; Retrospective Studies; Risk Factors; Substance Withdrawal Syndrome; Triazoles | 2014 |
Aspergilloma and massive haemoptysis.
Topics: Adult; Aneurysm, False; Angiography; Antifungal Agents; Embolization, Therapeutic; Female; Hemoptysis; Humans; Ill-Housed Persons; Mycetoma; Pulmonary Artery; Pulmonary Aspergillosis; Pyrimidines; Severity of Illness Index; Substance Abuse, Intravenous; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2014 |
Aerial prevalence of Aspergillus calidoustus isolates in and around a tertiary care hospital in Kuwait and assessment of their pathogenicity.
Topics: Air Microbiology; Animals; Antifungal Agents; Aspergillus; Bronchoalveolar Lavage Fluid; DNA, Fungal; Humans; Kuwait; Mice, Inbred BALB C; Microbial Sensitivity Tests; Molecular Sequence Data; Prevalence; Pulmonary Aspergillosis; Sequence Analysis, DNA; Tertiary Care Centers; Triazoles | 2014 |
Invasive cardiac aspergillosis after orthotopic liver transplantation.
Topics: Acute Disease; Caspofungin; Drug Therapy, Combination; Echinocandins; Echocardiography, Transesophageal; Hepatitis B; Humans; Lipopeptides; Liver Failure; Liver Transplantation; Lung; Magnetic Resonance Imaging; Male; Middle Aged; Myocarditis; Myocardium; Opportunistic Infections; Postoperative Complications; Pulmonary Aspergillosis; Triazoles | 2014 |
[Two cases of pulmonary aspergilosis, which deteriorated with generic itraconazole].
Topics: Antifungal Agents; Drugs, Generic; Humans; Itraconazole; Lung; Male; Middle Aged; Pulmonary Aspergillosis; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2014 |
Visual Hallucinations Associated with High Posaconazole Concentrations in Serum.
Topics: Aged; Antifungal Agents; Female; Hallucinations; Humans; Pulmonary Aspergillosis; Treatment Outcome; Triazoles | 2016 |
Galactomannan enzyme immunoassay and quantitative Real Time PCR as tools to evaluate the exposure and response in a rat model of aspergillosis after posaconazole prophylaxis.
Topics: Animals; Antifungal Agents; Biomarkers; Galactose; Immunoenzyme Techniques; Mannans; Pulmonary Aspergillosis; Rats; Real-Time Polymerase Chain Reaction; Triazoles | 2016 |
Triazole resistance in Aspergillus fumigatus isolates from patients with cystic fibrosis in Italy.
Topics: Adolescent; Adult; Antifungal Agents; Aspergillus fumigatus; Child; Cystic Fibrosis; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Environment; Female; Fungal Proteins; Humans; Italy; Male; Microbial Sensitivity Tests; Point Mutation; Prevalence; Pulmonary Aspergillosis; Triazoles | 2017 |
Predictors of mortality in chronic pulmonary aspergillosis.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; C-Reactive Protein; Chronic Disease; Female; Humans; Lung; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Prognosis; Pulmonary Aspergillosis; Pulmonary Disease, Chronic Obstructive; Quality of Life; Retrospective Studies; Risk Factors; Serum Albumin, Human; Survival Analysis; Triazoles; United Kingdom; Young Adult | 2017 |
Concomitant use of voriconazole and rifabutin in a patient with multiple infections.
Topics: Adult; Antibiotics, Antitubercular; Antifungal Agents; Aspergillus fumigatus; Drug Interactions; Female; Humans; Mycobacterium Infections, Nontuberculous; Mycobacterium xenopi; Pulmonary Aspergillosis; Pyrimidines; Rifabutin; Triazoles; Voriconazole | 2008 |
Comparative study on the efficacy of liposomal amphotericin B and voriconazole in a murine pulmonary aspergillosis model.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillus fumigatus; Disease Models, Animal; Lung; Male; Mice; Pulmonary Aspergillosis; Pyrimidines; Triazoles; Voriconazole | 2009 |
[Usefulness of monitoring plasma voriconazole concentration in patients with chronic necrotizing pulmonary aspergillosis].
Topics: Aged; Aged, 80 and over; Antifungal Agents; Female; Humans; Male; Middle Aged; Pulmonary Aspergillosis; Pyrimidines; Triazoles; Voriconazole | 2009 |
[Cerebral aspergillosis in an HIV-infected patient: unsuccessful outcome despite combined antifungal therapy. ].
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Brain Abscess; Caspofungin; Deoxycholic Acid; Drug Combinations; Drug Therapy, Combination; Echinocandins; Fatal Outcome; Humans; Leukoencephalopathy, Progressive Multifocal; Lipopeptides; Male; Middle Aged; Pulmonary Aspergillosis; Pyrimidines; Triazoles; Voriconazole | 2009 |
Combination therapy in treatment of experimental pulmonary aspergillosis: in vitro and in vivo correlations of the concentration- and dose- dependent interactions between anidulafungin and voriconazole by Bliss independence drug interaction analysis.
Topics: Anidulafungin; Animals; Antifungal Agents; Area Under Curve; Bronchoalveolar Lavage Fluid; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Echinocandins; Female; Galactose; Humans; Mannans; Pulmonary Aspergillosis; Pyrimidines; Rabbits; Triazoles; Voriconazole | 2009 |
Aspergillus vertebral osteomyelitis and epidural abscess.
Topics: Administration, Oral; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Diagnosis, Differential; Epidural Abscess; Fatal Outcome; Humans; Infusions, Intravenous; Laminectomy; Magnetic Resonance Imaging; Male; Middle Aged; Osteomyelitis; Pneumonectomy; Postoperative Complications; Pulmonary Aspergillosis; Pyrimidines; Spinal Cord Compression; Spondylitis; Thoracic Vertebrae; Triazoles; Voriconazole | 2009 |
A newly developed lung nodule during chemotherapy for small cell lung cancer. Chronic necrotising pulmonary aspergillosis.
Topics: Aged; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chronic Disease; Etoposide; Humans; Lung Neoplasms; Male; Pulmonary Aspergillosis; Pyrimidines; Small Cell Lung Carcinoma; Triazoles; Voriconazole | 2009 |
Phenytoin-induced reduction of voriconazole serum concentration is not compensated by doubling the dosage.
Topics: Anticonvulsants; Antifungal Agents; Area Under Curve; Dose-Response Relationship, Drug; Drug Interactions; Female; Humans; Male; Middle Aged; Phenytoin; Pulmonary Aspergillosis; Pyrimidines; Triazoles; Voriconazole | 2009 |
Periostitis secondary to prolonged voriconazole therapy in lung transplant recipients.
Topics: Adult; Aged; Alkaline Phosphatase; Antifungal Agents; Female; Humans; Lung Transplantation; Male; Middle Aged; Periostitis; Pulmonary Aspergillosis; Pyrimidines; Triazoles; Voriconazole | 2009 |
Acquired resistance to voriconazole and itraconazole in a patient with pulmonary aspergilloma.
Topics: Amino Acid Substitution; Antifungal Agents; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; DNA, Fungal; Fungal Proteins; Humans; Itraconazole; Male; Middle Aged; Mutation, Missense; Pulmonary Aspergillosis; Pyrimidines; Sequence Analysis, DNA; Triazoles; Voriconazole | 2010 |
[Porphyria cutanea tarda revealed by voriconazole].
Topics: Aged; Alcoholism; Antifungal Agents; Cheilitis; Feces; Humans; Liver; Male; Photosensitivity Disorders; Porphyria Cutanea Tarda; Porphyrins; Pulmonary Aspergillosis; Pyrimidines; Triazoles; Uroporphyrinogen Decarboxylase; Voriconazole | 2010 |
Antifungal management.
Topics: Amphotericin B; Antifungal Agents; Cord Blood Stem Cell Transplantation; Echinocandins; Humans; Leukemia; Lung; Male; Middle Aged; Neutropenia; Postoperative Complications; Pulmonary Aspergillosis; Pyrimidines; Triazoles; Voriconazole | 2010 |
Voriconazole-micafungin combination therapy for acute lymphoblastic leukemia.
Topics: Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Candida tropicalis; Candidiasis; Drug Therapy, Combination; Echinocandins; Follow-Up Studies; Fungemia; Humans; Infant; Lipopeptides; Male; Micafungin; Opportunistic Infections; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pulmonary Aspergillosis; Pyrimidines; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2010 |
Aspergillus niger: an unusual cause of invasive pulmonary aspergillosis.
Topics: Aged; Antifungal Agents; Aspergillus niger; Female; Humans; Lung; Pulmonary Aspergillosis; Pyrimidines; Triazoles; Voriconazole | 2010 |
A case of Aspergillus empyema successfully treated with combination therapy of voriconazole and micafungin: excellent penetration of voriconazole and micafungin into pleural fluid.
Topics: Aspergillus fumigatus; Drug Therapy, Combination; Echinocandins; Empyema, Pleural; Humans; Lipopeptides; Male; Micafungin; Middle Aged; Pleural Effusion; Pulmonary Aspergillosis; Pyrimidines; Triazoles; Voriconazole | 2010 |
Voriconazole inhibition of vitamin A metabolism: are adverse events increased in cystic fibrosis patients?
Topics: Adolescent; Antifungal Agents; Child; Cohort Studies; Cystic Fibrosis; Dietary Supplements; Female; Humans; Male; Photosensitivity Disorders; Pulmonary Aspergillosis; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Vision Disorders; Vitamin A; Voriconazole | 2010 |
Invasive respiratory aspergillosis is a treatable disease with early diagnosis and aggressive therapy.
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Child; Early Diagnosis; Echinocandins; Female; Fever; Hematologic Neoplasms; Humans; Lipopeptides; Male; Neutropenia; Prognosis; Pulmonary Aspergillosis; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Voriconazole | 2010 |
Case report 2: Fungal infections in chronic obstructive pulmonary disease.
Topics: Anti-Inflammatory Agents; Antifungal Agents; Aspergillus fumigatus; Belgium; Humans; Injections, Intravenous; Male; Middle Aged; Pulmonary Aspergillosis; Pulmonary Disease, Chronic Obstructive; Pyrimidines; Radiography, Thoracic; Steroids; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2010 |
Invasive pulmonary aspergillosis due to Aspergillus terreus: value of DNA, galactomannan and (1->3)-beta-D-glucan detection in serum samples as an adjunct to diagnosis.
Topics: Antifungal Agents; beta-Glucans; Child; Galactose; Humans; Lung Diseases, Fungal; Male; Mannans; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Proteoglycans; Pulmonary Aspergillosis; Pyrimidines; Triazoles; Voriconazole | 2010 |
Pulmonary aspergillosis in a non-neutropenic critical patient.
Topics: Antifungal Agents; Bronchoalveolar Lavage Fluid; Bronchoscopy; Burns, Inhalation; Caspofungin; Diagnosis, Differential; Drug Therapy, Combination; Echinocandins; Follow-Up Studies; Humans; Hydrogen Sulfide; Intensive Care Units; Lipopeptides; Male; Middle Aged; Pulmonary Aspergillosis; Pyrimidines; Respiratory Distress Syndrome; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2010 |
Posaconazole for chronic pulmonary aspergillosis: the next strategy against the threat of azole-resistant Aspergillus infection.
Topics: Antifungal Agents; Aspergillus; Drug Resistance, Fungal; Humans; Pulmonary Aspergillosis; Treatment Outcome; Triazoles | 2010 |
Efficacy and safety of posaconazole for chronic pulmonary aspergillosis.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Fungal; Antifungal Agents; Aspergillus; Chronic Disease; Female; Humans; Lung; Male; Microbial Sensitivity Tests; Middle Aged; Pulmonary Aspergillosis; Radiography, Thoracic; Retrospective Studies; Serum; Treatment Failure; Treatment Outcome; Triazoles | 2010 |
Pulmonary aspergillosis caused by a pan-azole-resistant Aspergillus fumigatus in a 10-year-old boy.
Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Azoles; Chemoprevention; Child; Drug Resistance, Multiple, Fungal; Hematopoietic Stem Cell Transplantation; Humans; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pulmonary Aspergillosis; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2011 |
Multifocal nodular periostitis associated with prolonged voriconazole therapy in a lung transplant recipient.
Topics: Aged; Antifungal Agents; Aspergillus fumigatus; Female; Graft Rejection; Humans; Immunosuppressive Agents; Lung Transplantation; Opportunistic Infections; Periostitis; Pulmonary Aspergillosis; Pulmonary Disease, Chronic Obstructive; Pyrimidines; Radiography; Radionuclide Imaging; Triazoles; Voriconazole | 2011 |
Management of voriconazole hepatotoxicity in a lung transplant patient.
Topics: Alanine Transaminase; Antifungal Agents; Aspartate Aminotransferases; Chemical and Drug Induced Liver Injury; Dose-Response Relationship, Drug; Drug Monitoring; Female; Humans; Lung Transplantation; Middle Aged; Pulmonary Aspergillosis; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2011 |
[Fatal outcome of invasive tracheal aspergillosis].
Topics: Antifungal Agents; Bronchi; Carotid Artery, External; Caspofungin; Contrast Media; Echinocandins; Fatal Outcome; Hemoptysis; Humans; Image Processing, Computer-Assisted; Iohexol; Lipopeptides; Male; Opportunistic Infections; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pulmonary Aspergillosis; Pyrimidines; Tomography, Spiral Computed; Trachea; Tracheal Diseases; Triazoles; Voriconazole; Young Adult | 2011 |
Breakthrough lung Scedosporium prolificans infection with multiple cavity lesions in a patient receiving voriconazole for probable invasive aspergillosis associated with monoclonal gammopathy of undetermined significance (MGUS).
Topics: Antifungal Agents; Fatal Outcome; Humans; Lung Diseases, Fungal; Male; Middle Aged; Mycetoma; Paraproteinemias; Pulmonary Aspergillosis; Pyrimidines; Scedosporium; Triazoles; Voriconazole | 2011 |
High-frequency triazole resistance found In nonculturable Aspergillus fumigatus from lungs of patients with chronic fungal disease.
Topics: Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Aspergillus fumigatus; Bronchoalveolar Lavage Fluid; Chronic Disease; Culture Media; DNA, Fungal; Drug Resistance, Fungal; Humans; Invasive Pulmonary Aspergillosis; Lung; Mutation; Polymerase Chain Reaction; Pulmonary Aspergillosis; Sputum; Triazoles | 2011 |
Oral voriconazole for neutropenia: a leukemia patient with probable pulmonary aspergillosis and scedosporidiosis.
Topics: Administration, Oral; Aged; Antifungal Agents; Female; Humans; Leukemia; Neutropenia; Pulmonary Aspergillosis; Pyrimidines; Triazoles; Voriconazole | 2011 |
[Intralobar pulmonary sequestration with aspergillosis in an asymptomatic 39-year-old man].
Topics: Adult; Bronchopulmonary Sequestration; Humans; Male; Pulmonary Aspergillosis; Pyrimidines; Radiography; Thoracotomy; Treatment Outcome; Triazoles; Voriconazole | 2011 |
Targeted disruption of nonribosomal peptide synthetase pes3 augments the virulence of Aspergillus fumigatus.
Topics: Animals; Animals, Outbred Strains; Antifungal Agents; Aspergillus fumigatus; Cell Line; Fungal Proteins; Gene Deletion; Macrophages; Mice; Moths; Peptide Synthases; Phenotype; Pulmonary Aspergillosis; Pyrimidines; Triazoles; Virulence; Voriconazole | 2011 |
Long-term treatment of invasive sinus, tracheobroncheal, pulmonary and intracerebral aspergillosis in acute lymphoblastic leukaemia.
Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Brain; Caspofungin; Cerebrum; Echinocandins; Humans; Larynx; Lipopeptides; Lung; Magnetic Resonance Imaging; Male; Middle Aged; Neuroaspergillosis; Paranasal Sinuses; Peripheral Nervous System Diseases; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pulmonary Aspergillosis; Pyrimidines; Sweden; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2012 |
Voriconazole-induced QT interval prolongation and torsades de pointes.
Topics: Adolescent; Antifungal Agents; Child; Electrocardiography; Endocarditis; Female; Humans; Long QT Syndrome; Male; Pulmonary Aspergillosis; Pyrimidines; Torsades de Pointes; Triazoles; Trichosporonosis; Voriconazole | 2011 |
Isolation of multiple-triazole-resistant Aspergillus fumigatus strains carrying the TR/L98H mutations in the cyp51A gene in India.
Topics: Antifungal Agents; Aspergillus fumigatus; Cluster Analysis; Cytochrome P-450 Enzyme System; DNA, Fungal; Drug Resistance, Fungal; Fungal Proteins; Humans; India; Male; Microbial Sensitivity Tests; Middle Aged; Mutation, Missense; Pulmonary Aspergillosis; Real-Time Polymerase Chain Reaction; Sequence Analysis, DNA; Sequence Homology; Triazoles | 2012 |
[Pulmonary aspergillosis and HIV infection: about two cases].
Topics: Adult; Antifungal Agents; Aspergillosis; Bronchoalveolar Lavage; HIV Infections; Humans; Lung Diseases, Fungal; Male; Middle Aged; Prognosis; Pulmonary Aspergillosis; Pyrimidines; Radiography; Risk Factors; Triazoles; Voriconazole | 2012 |
Mevalonate governs interdependency of ergosterol and siderophore biosyntheses in the fungal pathogen Aspergillus fumigatus.
Topics: Amphotericin B; Animals; Aspergillus fumigatus; Biomass; Biosynthetic Pathways; Enoyl-CoA Hydratase; Ergosterol; Ferric Compounds; Gene Deletion; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Fungal; Gene Silencing; Genes, Fungal; Hydroxamic Acids; Hydroxymethylglutaryl CoA Reductases; Iron Deficiencies; Ligases; Lovastatin; Mevalonic Acid; Mice; Microbial Sensitivity Tests; Oxidative Stress; Pulmonary Aspergillosis; Pyrimidines; Siderophores; Triazoles; Up-Regulation; Virulence; Voriconazole | 2012 |
[Photo quiz: Deep-seated mycosis].
Topics: Antifungal Agents; Fatal Outcome; Humans; Lung Diseases, Fungal; Male; Middle Aged; Polymerase Chain Reaction; Pulmonary Aspergillosis; Pyrimidines; RNA, Fungal; Scedosporium; Sputum; Triazoles; Voriconazole | 2012 |
Correlation between triazole treatment history and susceptibility in clinically isolated Aspergillus fumigatus.
Topics: Aged; Aged, 80 and over; Antifungal Agents; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Female; Fungal Proteins; Humans; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Mutation; Pulmonary Aspergillosis; Time Factors; Triazoles | 2012 |
Remarkably efficient inhaled antifungal monotherapy for invasive pulmonary aspergillosis.
Topics: Administration, Inhalation; Aged; Antifungal Agents; Humans; Male; Pulmonary Aspergillosis; Pyrimidines; Triazoles; Voriconazole | 2012 |
Switching from intravenous to oral tacrolimus and voriconazole leads to a more pronounced drug-drug interaction.
Topics: Antifungal Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Availability; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Drug Monitoring; Humans; Immunosuppressive Agents; Liver Transplantation; Male; Middle Aged; Pulmonary Aspergillosis; Pyrimidines; Tacrolimus; Triazoles; Voriconazole | 2013 |
In vitro-in vivo correlation of voriconazole resistance due to G448S mutation (cyp51A gene) in Aspergillus fumigatus.
Topics: Animals; Antifungal Agents; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; Disease Models, Animal; Drug Resistance, Fungal; Female; Fungal Proteins; Humans; Mice; Mice, Inbred ICR; Mutation, Missense; Pulmonary Aspergillosis; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2012 |
Efficacy and safety of voriconazole in the treatment of chronic pulmonary aspergillosis: experience in Japan.
Topics: Aged; Antifungal Agents; Chronic Disease; Dose-Response Relationship, Drug; Female; Humans; Japan; Male; Middle Aged; Prospective Studies; Pulmonary Aspergillosis; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2012 |
Breakthrough pulmonary Aspergillus fumigatus infection with multiple triazole resistance in a Spanish patient with chronic myeloid leukemia.
Topics: Adult; Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillus fumigatus; Caspofungin; Combined Modality Therapy; Cytochrome P-450 Enzyme System; Drug Resistance, Multiple, Fungal; Echinocandins; Fatal Outcome; Female; Fungal Proteins; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Immunosuppressive Agents; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lipopeptides; Point Mutation; Postoperative Complications; Pulmonary Aspergillosis; Recurrence; Spain; Species Specificity; Transplantation Conditioning; Transplantation, Homologous; Triazoles | 2013 |
Effect of PTX3 and voriconazole combination in a rat model of invasive pulmonary aspergillosis.
Topics: Animals; Antifungal Agents; Body Burden; C-Reactive Protein; Colony Count, Microbial; Cortisone; Drug Combinations; Galactose; Immunosuppressive Agents; Kaplan-Meier Estimate; Lung; Mannans; Organ Size; Pulmonary Aspergillosis; Pyrimidines; Rats; Respiratory Function Tests; Serum Amyloid P-Component; Survival; Triazoles; Voriconazole | 2012 |
Major variations in Aspergillus fumigatus arising within aspergillomas in chronic pulmonary aspergillosis.
Topics: Adult; Antifungal Agents; Aspergillus fumigatus; Chronic Disease; Female; Genetic Variation; Humans; Itraconazole; Microbial Sensitivity Tests; Microsatellite Repeats; Middle Aged; Molecular Typing; Mycological Typing Techniques; Pulmonary Aspergillosis; Pyrimidines; Triazoles; Voriconazole | 2013 |
A 56-year-old man with undifferentiated fever in the ICU and endobronchial plaques.
Topics: Antifungal Agents; Aspergillus fumigatus; Bronchitis; Bronchoscopy; Colectomy; Fever; Humans; Intensive Care Units; Intestinal Diseases; Lung; Male; Middle Aged; Pulmonary Aspergillosis; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2013 |
Simultaneous mold infections in an orthotopic heart transplant recipient.
Topics: Amphotericin B; Antibodies, Monoclonal; Antifungal Agents; Aspergillus fumigatus; Basiliximab; Cardiomyopathy, Dilated; Debridement; Dermatomycoses; Heart Transplantation; Humans; Immunocompromised Host; Immunosuppressive Agents; Injections, Intravenous; Male; Middle Aged; Mucormycosis; Prosthesis-Related Infections; Pulmonary Aspergillosis; Pyrimidines; Recombinant Fusion Proteins; Rhizopus; Triazoles; Voriconazole | 2008 |